Kathleen M. Sanzo


Kathleen M. Sanzo centers her practice on regulatory and compliance issues connected to products regulated by the US Food and Drug Administration (FDA). She leads and counsels clients on matters relating to prescription, OTC drug, and biotechnology products clinical testing; food, dietary supplement, and cosmetic product manufacture, approval, marketing, and distribution; device promotion and labeling issues; food, drug, and device compliance matters; and all consumer product issues regulated by the US Consumer Product Safety Commission (CPSC) and state enforcement agencies.


8/6/2019 - Can C.B.D. Be Used in Foods? Reply Hazy, Try Again, Baking Business

4/5/2019 - C.B.D.: The Risks vs. the Reward, Baking Business

4/5/2019 - FDA's Puzzle: Measuring How DSHEA Fits for Supplement Industry Oversight, The Pink Sheet

3/22/2019 - Attorneys: CBD Concentration, Supply Chains Will Be Questioned by FDA During April Public Comments

1/3/2019 - Morgan Lewis Launches As Prescribed Blog on Issues Facing Pharma, Biotech Sectors

10/15/2018 - Industry Should Seek Guidance, Supply-Chain Checks for California Cruelty-Free Compliance, Rose Sheet

9/5/2018 - FDA Focus: What Morgan Lewis' Practice Chair Is Watching, Law360

April 2018 - Life Sciences 2018: Regulatory Analysis, Who's Who Legal

12/12/2017 - Morgan Lewis Advises Repros Therapeutics in Sale to Allergan

5/15/2017 - More than 35 Morgan Lewis Lawyers Named Top Women in the Law by Best Lawyers

6/20/2016 - Morgan Lewis Forum to Highlight Global Regulatory and Transactional Considerations for Growing Life Sciences Companies

5/3/2016 - 35 Morgan Lewis Lawyers Recognized by Best Lawyers in America as Top Women in the Law

12/4/2015 - Morgan Lewis Advises Axsome Therapeutics in $51M IPO Closing

10/15/2015 - Morgan Lewis Life Sciences Capabilities Recognized in 2015 LMG Life Sciences Guides

6/26/2015 - Morgan Lewis Represents General Econopak in $175 Million Sale to Steris Corporation

1/14/2015 - Life Sciences Group Of The Year: Morgan Lewis, Law360

11/21/2014 - Morgan Lewis Advises Merck KGaA in Global Agreement with Pfizer Inc.

9/29/2014 - LMG Life Sciences Praises Morgan Lewis’s Life Sciences Capabilities

9/22/2014 - FDA Practice Leader Named “U.S. Regulatory Attorney of the Year”

7/16/2014 - Morgan Lewis Advises InnoPharma on $225 Million Acquisition by Pfizer

5/22/2014 - Morgan Lewis Advises Agile Therapeutics on IPO

3/24/2014 - Morgan Lewis Advises TC Transcontinental on Capri Packaging Acquisition

2/4/2014 - Morgan Lewis Advises Chiesi on Completed Cornerstone Acquisition

1/7/2014 - Twelve Morgan Lewis Partners Named to Washingtonian’s Best Lawyers Listing

10/3/2013 - Morgan Lewis Receives 2013 LMG Life Sciences Awards

9/16/2013 - Morgan Lewis Advises Chiesi Farmaceutici on Merger Agreement with Cornerstone Therapeutics

1/7/2013 - Life Sciences Regulation To Watch In 2013, Law360

4/9/2012 - Morgan Lewis Advises Sun Capital on Acquisition of CornerStone

5/28/2010 - Attorneys See Uncertainty in FDA's Implementation of Biosimilar Approvals, Life Sciences Law & Industry Report

View more...